Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Manlio Sgarzi
Observed names:
M. SGARZI,
M. Sgarzi,
Sgarzi, Manlio
Institution:
Ospedale Papa Giovanni XXIII
Observed institutions:
University of Milan,
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico,
Ospedale Papa Giovanni XXIII,
Fondazione IRCCS Istituto Neurologico Carlo Besta
ORCID:
0000-0002-6875-8542
Observed ORCID:
0000-0002-6875-8542
OpenAlex ID:
A5050860691
Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis
2019
·
James F. Howard
, Vera Bril
, et al.
·
Neurology
·
307
PDF
Neurologic manifestations in 1760 COVID-19 patients admitted to Papa Giovanni XXIII Hospital, Bergamo, Italy
2020
·
Nicola Rifino
, Bruno Censori
, et al.
·
Journal of Neurology
·
109
PDF
Real world study on prevalence, treatment and economic burden of myasthenia gravis in Italy
2023
·
Giovanni Antonini
, Francesco Habetswallner
, et al.
·
Heliyon
·
37
PDF
A standardized protocol for the perioperative management of myasthenia gravis patients. Experience with 110 patients
2011
·
P. GRITTI
, M. SGARZI
, et al.
·
Acta Anaesthesiologica Scandinavica
·
36
Therapeutic challenges and unmet needs in the management of myasthenia gravis: an Italian expert opinion
2024
·
Renato Mantegazza
, Francesco Saccà
, et al.
·
Neurological Sciences
·
15
Serum IgG antibodies to a 35-kDa P0-related glycoprotein in motor neuron disease
1994
·
Eduardo Nobile-Orazio
, Emanuela Manfredini
, et al.
·
Journal of Neuroimmunology
·
13
Efficacy and safety of cemdisiran siRNA in myasthenia gravis (NIMBLE): a double-blind, randomised, placebo-controlled, phase 3 trial
2026
·
Tuan Vu
, Ali A Habib
, et al.
·
The Lancet
·
12
Incidence of orolingual angioedema after intravenous thrombolysis for stroke
2018
·
Bruno Censori
, T. Partziguian
, et al.
·
Neurological Sciences
·
10
Real world study in Italian public hospital with Efgartigimod in patients affected by generalized myasthenia gravis: influence of clinical and serological factors
2025
·
Manlio Sgarzi
, Paolo Paone
, et al.
·
Frontiers in Neurology
·
9
PDF
Efficacy and Safety of Gefurulimab in Generalized Myasthenia Gravis: The PREVAIL Phase 3 Randomized Clinical Trial
2026
·
Kelly G. Gwathmey
, Francesco Saccà
, et al.
·
JAMA Neurology
·
5
Estimation of myasthenia gravis prevalence in Italy using real-world data
2021
·
Giovanni Antonini
, Francesco Habetswallner
, et al.
·
Journal of the Neurological Sciences
·
4
Efficacy and Safety of Vemircopan in Generalized Myasthenia Gravis: A Randomized Clinical Trial
2026
·
Francesco Saccà
, Gino Gialdini
, et al.
·
JAMA Neurology
·
3
Anticonvulsant drugs in migraine prophylaxis
2001
·
Fabio Frediani
, Francesca Cominelli
, et al.
·
The Journal of Headache and Pain
·
3
PDF
Ravulizumab in the Management of Refractory Myasthenic Crisis: Clinical and Ventilatory Evidence of Early Recovery—A Case Report
2025
·
Manlio Sgarzi
, Paolo Paone
, et al.
·
Case Reports in Neurological Medicine
·
1
PDF
Aspects of Clinical Preparation of Thymectomy in Myasthenic Cases with or without Thymoma and the Clinico-Biological Follow-up of the Thymectomized Patients
1997
·
Paolo Confalonieri
, Renato Mantegazza
, et al.
·
Springer eBooks
Show more works
View as search
Works count:
16
Citation count:
564
H-index:
9
I10-index:
8
Year
Topic
Type